FIRST-IN-HUMAN PHASE I/II CLINICAL TRIAL OF IG-TREGS FOR GVHD PREVENTION

被引：0

作者：

Lysandrou, Memnon ^{[1
]}

Kefala, Dionysia ^{[1
]}

Christofi, Panagiota ^{[1
,2
]}

Liga, Maria ^{[1
]}

Miggos, Antonis ^{[3
]}

Papagregoriou, Charys ^{[4
]}

Vlachonikola, Elisavet ^{[3
]}

Savvopoulos, Nikolaos ^{[1
]}

Zacharioudaki, Vassiliki ^{[1
]}

Vallianou, Ioanna ^{[2
]}

Sagiadinou, Eleutheria ^{[1
]}

Tsokanas, Dimitris ^{[1
]}

Theodorellou, Rodanthy ^{[5
]}

Papadopoulou, Anastasia ^{[2
]}

Triantafyllou, Evi ^{[1
]}

Sakellari, Ioanna ^{[2
]}

Costeas, Paul ^{[4
,6
]}

Chatzidimitriou, Anastasia ^{[3
]}

Yannaki, Evangelia ^{[2
]}

Spyridonidis, Alexandros ^{[1
]}

机构：

[1] Univ Patras, Univ Gen Hosp Patras, Patras, Greece

[2] George Papanikolaou Hosp, Thessaloniki, Greece

[3] Ctr Res & Technol Hellas, Inst Appl Biosci, Thessaloniki, Greece

[4] Ctr Study Hematol & Other Malignancies, Nicosia, Cyprus

[5] Pharmassist Ltd, Athens, Greece

[6] Karaiskakio Fdn, Nicosia, Cyprus

来源：

BONE MARROW TRANSPLANTATION | 2024年 / 59卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P568

引用

页码：534 / 535

页数：2

共 50 条

[1] FIRST-IN-HUMAN PHASE I/II CLINICAL TRIAL OF IG-TREGS FOR GVHD PREVENTION
Lysandrou, M.
Kefala, D.
Christofi, P.
Liga, M.
Miggos, A.
Papagregoriou, C.
Vlachonikola, E.
Savvopoulos, N.
Zacharioudaki, V.
Vallianou, I.
Sagiadinou, E.
Tsokanas, D.
Theodorelou, R.
Papadopoulou, A.
Triantafyllou, E.
Sakellari, I.
Costeas, P.
Chatzidimitriou, A.
Yannaki, E.
Spyridonidis, A.
CYTOTHERAPY, 2024, 26 (06) : S12 - S12
[2] Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial
Roberto Crocchiolo
Clara Cesana
Debora Girgenti
Giambattista Bertani
Claudia Barba
Giuseppa Liga
Ursula Ferri
Lara Crucitti
Giovanni Grillo
Silvano Rossini
Roberto Cairoli
Experimental Hematology & Oncology, 10
[3] Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial
Roberto, Crocchiolo
Clara, Cesana
Debora, Girgenti
Giambattista, Bertani
Claudia, Barba
Giuseppa, Liga
Ursula, Ferri
Lara, Crucitti
Giovanni, Grillo
Silvano, Rossini
Roberto, Cairoli
EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2021, 10 (01)
[4] Correction to: Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial
Roberto Crocchiolo
Clara Cesana
Debora Girgenti
Giambattista Bertani
Claudia Barba
Giuseppa Liga
Ursula Ferri
Lara Crucitti
Giovanni Grillo
Silvano Rossini
Roberto Cairoli
Experimental Hematology & Oncology, 10
[5] VLP peanut first-in-human Phase I clinical trial: Patient centred selection approach
Starchenka, Sviatlana
Zuiani, Chiara
Wilkie, David
Eser, Sema
Meneghesso, Silvia
Adura, Peter
McArdle, Eamonn
Schroeder, John
Hamilton, Robert
Skinner, Murray
Kramer, Matthias
Cadavez, Lisa
Shamji, Mohamed
Layhadi, Janice
De Kam, Pieter-Jan
CLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (10): : 844 - 845
[6] A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles for potent melanoma immunotherapy
Jabulowsky, Robert A.
Loquai, Carmen
Utikal, Jochen
Hassel, Jessica
Kaufmann, Roland
Derhovanessian, Evelyna
Diken, Mustafa
Kranz, Lena M.
Haas, Heinrich
Attig, Sebastian
Anft, Christine
Buck, Janina
Diekmann, Jan
Fritz, Daniel
Hartmann, Kerstin
Kemmer-Brueck, Alexandra
Kuehlcke, Klaus
Kuhn, Andreas N.
Langguth, Peter
Luxemburger, Ulrich
Meng, Martin
Rae, Richard
Sari, Fatih
Schwarck-Kokarakis, Doreen
Stein, Malte
Grabbe, Stephan
Kreiter, Sebastian
Tuereci, Oezlem
Huber, Christoph
Sahin, Ugur
CANCER RESEARCH, 2017, 77
[7] First-in-human phase I trial of DC immunotherapy for early RA
Jenny Buckland
Nature Reviews Rheumatology, 2015, 11 (8) : 443 - 443
[8] First-in-human phase I trial of a novel epothilone, KOS-1584.
Villalona-Calero, M.
Goel, S.
Schaaf, L.
McCracken, B.
Desai, K.
Cropp, G.
Zhou, Y.
Johnson, R. G.
Hannah, A. L.
Mani, S.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 79S - 79S
[9] Evaluation of NTP42, a novel thromboxane receptor antagonist, in a first-in-human phase I clinical trial
Reid, Helen M.
Maginn, Mark
Perkins, C. Michael
Mulvaney, Eamon P.
Boyce, Malcolm
Yamamoto, Takahiro
Kinsella, B. Therese
FRONTIERS IN PHARMACOLOGY, 2023, 14
[10] IVAC® MUTANOME - A first-in-human phase I clinical trial targeting individual mutant neoantigens for the treatment of melanoma
Miller, Matthias
Loquai, Carmen
Kloke, Bjorn-Philipp
Attig, Sebastian
Bidmon, Nicole
Bolte, Stefanie
Bukur, Valesca
Derhovanessian, Evelyne
Diekmann, Jan
Filbry, Angela
Heesch, Sandra
Hoeller, Christoph
Kuehlcke, Klaus
Langer, David
Loewer, Martin
Mueller, Felicitas
Ortseifer, Inga
Otte, Burkhard
Paruzynski, Anna
Rae, Richard
Schroers, Barbara
Seck, Christine
Spiess, Kristina
Tadmor, Arbel D.
Vogler, Isabel
Vormehr, Mathias
Kemmer-Brueck, Alexandra
Kuhn, Andreas N.
Luxemburger, Ulrich
Kreiter, Sebastian
Utikal, Jochen
Grabbe, Stephan
Tuereci, Oezlem
Sahin, Ugur
CANCER RESEARCH, 2016, 76

← 1 2 3 4 5 →